Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy

Código QR

Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy

Ruma Maji, Niladri Shekhar Dey, Bhabani Sankar Satapathy, Biswajit Mukherjee, Subhasish MondalDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata (Calcutta), IndiaBackground: Four formulations of Tamoxifen citrate loaded polylactide-co-glycolide (PLGA) based nanoparticles (TNPs) w...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Maji R, Dey NS, Satapathy BS, Mukherjee B, Mondal S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/58fb07e6f91144ddb6b32e1b9bafbb59
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation
por: Basudev Sahana, et al.
Publicado: (2010)

Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
por: Adehin A, et al.
Publicado: (2020)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

Combination treatment of tamoxifen with risperidone in breast cancer.
por: Wei-Lan Yeh, et al.
Publicado: (2014)

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
por: Tommaso De Marchi, et al.
Publicado: (2017)

Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells
por: Chaves NL, et al.
Publicado: (2017)

Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
por: Biswajit Mukherjee, et al.
Publicado: (2008)

Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles
por: Omwoyo WN, et al.
Publicado: (2014)

Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients
por: Katayoun Derakhshandeh, et al.
Publicado: (2010)

LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
por: Zhang Hongkai, et al.
Publicado: (2020)

Preparation, characterization and systemic application of self-assembled hydroxyethyl starch nanoparticles-loaded flavonoid Morin for hyperuricemia therapy
por: Li J, et al.
Publicado: (2018)

Disruption of the ER-α36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells.
por: Li Yin, et al.
Publicado: (2014)

Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines
por: Alyafee YA, et al.
Publicado: (2017)

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
por: Butani D, et al.
Publicado: (2021)

Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil
por: Shi F, et al.
Publicado: (2012)

Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study
por: Basu S, et al.
Publicado: (2012)

Differential response to α-oxoaldehydes in tamoxifen resistant MCF-7 breast cancer cells.
por: Norbert Nass, et al.
Publicado: (2014)

Diethyl citrate and sodium citrate reduce the cytotoxic effects of nanosized hydroxyapatite crystals on mouse vascular smooth muscle cells
por: Zhang CY, et al.
Publicado: (2017)

Functionalization Of T Lymphocytes With Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles For Magnetically Controlled Immune Therapy
por: Mühlberger M, et al.
Publicado: (2019)

Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy
por: Sijin Guo, et al.
Publicado: (2020)

Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles
por: Elnaggar YS, et al.
Publicado: (2011)

Tamoxifen therapy in a murine model of myotubular myopathy
por: Nika Maani, et al.
Publicado: (2018)

Effect of tamoxifen with or without gonadotropin-releasing hormone analog on DXA values in women with breast cancer
por: Eun Heui Kim, et al.
Publicado: (2021)

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse
por: A. B. Sanchez-Spitman, et al.
Publicado: (2021)

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
por: Katherine D. Crew, et al.
Publicado: (2017)

Evaluating the Risk of Breast Cancer Recurrence and Metastasis After Adjuvant Tamoxifen Therapy by Integrating Polymorphisms in Cytochrome P450 Genes and Clinicopathological Characteristics
por: Hui Pang, et al.
Publicado: (2021)

Preparation and in vitro/in vivo characterization of enteric-coated nanoparticles loaded with the antihypertensive peptide VLPVPR
por: Sun HY, et al.
Publicado: (2014)

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset
por: Per Damkier, et al.
Publicado: (2017)

Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells
por: et al, et al.
Publicado: (2011)

Preparation, Characterization, and Pharmacological Investigation of Withaferin-A Loaded Nanosponges for Cancer Therapy; In Vitro, In Vivo and Molecular Docking Studies
por: Hamid Saeed Shah, et al.
Publicado: (2021)

Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
por: Takayuki Watanabe, et al.
Publicado: (2021)

Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
por: Maura Harrigan, et al.
Publicado: (2021)

Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients
por: Carla Miranda, et al.
Publicado: (2021)

Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy
por: Oh KS, et al.
Publicado: (2016)

Targeting Engineered Nanoparticles for Breast Cancer Therapy
por: Kumar Ganesan, et al.
Publicado: (2021)

Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy
por: Li C, et al.
Publicado: (2013)

Design and Characterization of Maltoheptaose-<i>b</i>-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen
por: Marcos Antonio Villetti, et al.
Publicado: (2021)

LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
por: Qianfeng Shi, et al.
Publicado: (2020)

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
por: Sanne Løkkegaard, et al.
Publicado: (2021)

Synthesis, structural characterization and catalytic application of citrate-stabilized monometallic and bimetallic palladium@copper nanoparticles in microbial anti-activities
por: Ullah I, et al.
Publicado: (2017)